KOMBIGLYZE XR 5-500 MG TABLET

SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE
$15.4800per EA
Discontinued

Strength

500; 5 mg/1; mg/1

NDC

00310613530

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

1/1/2023

Approval Type

New Drug (NDA)

FDA Application

NDA200678

On Market Since

12/4/2014

Pharmacological Classes

Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+6.1%

All

+48.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.